These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 8738659)
21. Novel acceptor splice site mutation in the invariant AG of intron 6 of alpha-galactosidase A gene, causing Fabry disease. Mutations in brief no. 146. Online. Matsumura T; Osaka H; Sugiyama N; Kawanishi C; Maruyama Y; Suzuki K; Onishi H; Yamada Y; Morita M; Aoki M; Kosaka K Hum Mutat; 1998; 11(6):483. PubMed ID: 10200059 [TBL] [Abstract][Full Text] [Related]
22. Galactose stabilizes various missense mutants of alpha-galactosidase in Fabry disease. Okumiya T; Ishii S; Takenaka T; Kase R; Kamei S; Sakuraba H; Suzuki Y Biochem Biophys Res Commun; 1995 Sep; 214(3):1219-24. PubMed ID: 7575533 [TBL] [Abstract][Full Text] [Related]
23. Enzymatic corrections for cells derived from Fabry disease patients by a recombinant adenovirus vector. Ohsugi K; Kobayashi K; Itoh K; Sakuraba H; Sakuragawa N J Hum Genet; 2000; 45(1):1-5. PubMed ID: 10697955 [TBL] [Abstract][Full Text] [Related]
24. Fabry disease: identification of novel alpha-galactosidase A mutations and molecular carrier detection by use of fluorescent chemical cleavage of mismatches. Germain DP; Poenaru L Biochem Biophys Res Commun; 1999 Apr; 257(3):708-13. PubMed ID: 10208848 [TBL] [Abstract][Full Text] [Related]
25. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene. Eng CM; Desnick RJ Hum Mutat; 1994; 3(2):103-11. PubMed ID: 7911050 [TBL] [Abstract][Full Text] [Related]
26. New point mutation (R301X) of the alpha-galactosidase A gene causing Fabry disease. Kawanishi C; Osaka H; Inoue K; Onishi H; Yamada Y; Sugiyama N; Suzuki K; Hanihara T; Miyagawa T; Kimura S Hum Mutat; 1995; 6(2):186-7. PubMed ID: 7581405 [No Abstract] [Full Text] [Related]
27. Identification of novel mutations in the α-galactosidase A gene in patients with Fabry disease: pitfalls of mutation analyses in patients with low α-galactosidase A activity. Yoshimitsu M; Higuchi K; Miyata M; Devine S; Mattman A; Sirrs S; Medin JA; Tei C; Takenaka T J Cardiol; 2011 May; 57(3):345-53. PubMed ID: 21333496 [TBL] [Abstract][Full Text] [Related]
28. Atypical Fabry's disease. An oligosymptomatic variant. Ko YH; Kim HJ; Roh YS; Park CK; Kwon CK; Park MH Arch Pathol Lab Med; 1996 Jan; 120(1):86-9. PubMed ID: 8554452 [TBL] [Abstract][Full Text] [Related]
29. Clinical and molecular characterization of an extended family with Fabry disease. Wattanasirichaigoon D; Svasti J; Cairns JR; Tangnararatchakit K; Visudtibhan A; Keeratichamroen S; Ngiwsara L; Khowsathit P; Onkoksoong T; Lekskul A; Mongkolsiri D; Jariengprasert C; Thawil C; Ruencharoen S J Med Assoc Thai; 2006 Sep; 89(9):1528-35. PubMed ID: 17100396 [TBL] [Abstract][Full Text] [Related]
30. Identification of a novel mutation in the alpha-galactosidase A gene in patients with Fabry disease. Colomba P; Nucera A; Zizzo C; Albeggiani G; Francofonte D; Iemolo F; Tuttolomondo A; Pinto A; Duro G Clin Biochem; 2012 Jul; 45(10-11):839-41. PubMed ID: 22465271 [TBL] [Abstract][Full Text] [Related]
31. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele. Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108 [TBL] [Abstract][Full Text] [Related]
32. Two novel mutations in the alpha-galactosidase gene in Japanese classical hemizygotes with Fabry disease. Okumiya T; Takenaka T; Ishii S; Kase R; Kamei S; Sakuraba H Jpn J Hum Genet; 1996 Sep; 41(3):313-21. PubMed ID: 8996967 [TBL] [Abstract][Full Text] [Related]
33. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. Garman SC; Garboczi DN J Mol Biol; 2004 Mar; 337(2):319-35. PubMed ID: 15003450 [TBL] [Abstract][Full Text] [Related]
34. Fabry disease: twenty novel alpha-galactosidase A mutations causing the classical phenotype. Ashley GA; Shabbeer J; Yasuda M; Eng CM; Desnick RJ J Hum Genet; 2001; 46(4):192-6. PubMed ID: 11322659 [TBL] [Abstract][Full Text] [Related]
35. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes. Ashton-Prolla P; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ J Investig Med; 2000 Jul; 48(4):227-35. PubMed ID: 10916280 [TBL] [Abstract][Full Text] [Related]
36. Identification of a novel GLA mutation (Y88C) in a Korean family with Fabry nephropathy: a case report. Chong Y; Kim M; Koh ES; Shin SJ; Kim HS; Chung S BMC Med Genet; 2016 Oct; 17(1):76. PubMed ID: 27776503 [TBL] [Abstract][Full Text] [Related]
37. [Biochemical study of unusual cases of Fabry disease]. Beĭer EM; Karpova EA; Udalova OV; Tsvetkova IV Vopr Med Khim; 1998; 44(5):494-500. PubMed ID: 9916266 [TBL] [Abstract][Full Text] [Related]
38. Japanese patients with Fabry disease predominantly showing cardiac and neurological manifestation with novel missense mutation: R220P. Fukutomi M; Tanaka N; Uchinoumi H; Kanemoto M; Nakao F; Yamada J; Kamei T; Takenaka T; Fujii T J Cardiol; 2013 Jul; 62(1):63-9. PubMed ID: 23608164 [TBL] [Abstract][Full Text] [Related]
39. A case of multiple angiomas without any angiokeratomas in a female heterozygote with Fabry disease. Mirceva V; Hein R; Ring J; Möhrenschlager M Australas J Dermatol; 2010 Feb; 51(1):36-8. PubMed ID: 20148840 [TBL] [Abstract][Full Text] [Related]
40. Fabry disease: six gene rearrangements and an exonic point mutation in the alpha-galactosidase gene. Bernstein HS; Bishop DF; Astrin KH; Kornreich R; Eng CM; Sakuraba H; Desnick RJ J Clin Invest; 1989 Apr; 83(4):1390-9. PubMed ID: 2539398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]